Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket

Shares of Freshpet, Inc. gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company’s quarterly sales came in at $215.42 million versus expectations of $204.36 million.

Freshpet shares gained 15.5% to $106.29 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Akili, Inc. shares jumped 126% to $0.5009 after the company reported positive results from Shionogi's Phase 3 clinical trial of localized version of Akili's EndeavorRx® for Pediatric ADHD patients in Japan.
• ZyVersa Therapeutics, Inc. climbed 126% to $1.81 after surging over 30% on Friday.
• MicroCloud Hologram Inc. gained 107% to $13.71 after tumbling 40% on Friday.
• Neptune Wellness Solutions Inc. rose 54.6% to $0.49.
• Interactive Strength Inc. surged 32.2% to $0.8701 after the company announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR.
• Agiliti, Inc. gained 29.4% to $9.89 after the company announced it will be taken private by THL Partners.
• Krystal Biotech, Inc. surged 28.8% to $143.34 after the company reported better-than-expected financial results.
• R1 RCM Inc. surged 26.7% to $14.06 after the company received an acquisition offer for the company valued at $13.75 per share.
• Butterfly Network, Inc. gained 26.3% to $1.2880.
• Altimmune, Inc. surged 22.1% to $11.24.
• Milestone Pharmaceuticals Inc. gained 21.3% to $2.10 after the company announced plans to resubmit the New Drug Application (NDA) for etripamil to the U.S. Food and Drug Administration (FDA) for paroxysmal supraventricular tachycardia (PSVT).
• Ocugen, Inc. climbed 18.9% to $0.9451.
• ImmunityBio, Inc. gained 18% to $ 4.1250.
• Li Auto Inc. rose 16.2% to $40.44 after the company reported fourth-quarter financial results above estimates and issued first-quarter guidance.
• Nuwellis, Inc. shares rose 16.1% to $0.7101.
• SkyWater Technology, Inc. gained 15.4% to $10.98.
• ImmunityBio, Inc. gained 14.3% to $3.9999 after dipping 33% on Friday.
• Celldex Therapeutics, Inc. surged 13.9% to $43.00 following strong quarterly sales.
• Polestar Automotive Holding UK PLC gained 13.4% to $1.4850.
• Itron, Inc. rose 12.3% to $84.11 after the company reported fourth-quarter financial results and issued first-quarter guidance above estimates.
• HashiCorp, Inc. gained 11.8% to $24.77 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $23 to $30.
• Marathon Digital Holdings, Inc. jumped 11.2% to $26.67.
• NeuBase Therapeutics, Inc. shares surged 10.5% to $0.83. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets.
• Carmell Corporation rose 9.9% to $2.47. Carmell announced product development has been completed for Gold Limited Edition Exclusive launch in March 2024.
• Domino's Pizza, Inc. gained 8.2% to $469.01 after the company’s fourth quarter 2023 earnings surpassed Wall Street expectations, raised its quarterly dividend, and announced an additional share buyback plan.
• NIO Inc. rose 6.5% to $5.75. The company on Monday announced that it entered into a technology license agreement with Forseven Limited.
• Teva Pharmaceutical Industries Limited shares gained 4.3% to $13.44 after the company announced FDA approval of its arthritis treatment.

Losers

• Aclarion, Inc. shares fell 62.5% to $0.34 after the company priced its public offering of 5.175 million units. Each unit includes one share of common stock (or a pre-funded warrant), and two common warrants.
• Venus Concept Inc. dipped 28.8% to $0.93 after the company announced a $1.2 million registered direct offering at $1.465 per share.
• DIH Holding US, Inc. fell 28.3% to $0.79.
• ThermoGenesis Holdings, Inc. dipped 27.5% to $0.7601.
• Intuitive Machines, Inc. fell 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.
• Semilux International Ltd. declined 24.4% to $0.8615.
• Brera Holdings PLC fell 21.8% to $0.8601.
• Antelope Enterprise Holdings Limited dipped 21.8% to $1.50. Antelope Enterprise announced closing of $1.3 million registered direct offering and private placement.
• NGM Biopharmaceuticals, Inc. fell 19.4% to $1.5399. NGM Bio has entered into a definitive agreement and plan of merger with certain affiliates of the Column Group, LP.
• Telesis Bio, Inc. shares fell 17.8% to $0.6401. Telesis Bio shares jumped 72% on Friday after the company was granted EUR Patent #3503915 for "Genetically Engineered Vibrio Natriegens (Host Organism For Cloning And Manipulating DNA)."
• Beneficient fell 17% to $0.1640. On Feb. 13, Beneficient posted a third-quarter loss of $1.98 per share.
• Dogness (International) Corporation fell 17% to $6.14.
• AtlasClear Holdings, Inc. shares fell 11.2% to $2.3450 after jumping over 131% on Friday.
• Jin Medical International Ltd. declined 11.2% to $6.30.
• Roma Green Finance Limited fell 9.9% to $1.4599 after tumbling 11% on Friday.
• Surgery Partners, Inc. dipped 7.8% to $30.43 following weak quarterly sales.
• World Acceptance Corporation fell 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.

Now Read This: Intuit To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Carmell said Wednesday it has closed its merger with Axolotl Biologix, a developer of products for soft tissue repair, aesthetics, and orthopedic indications.

The company said that, as previously disclosed, the initial merger consideration comprises $8 million in cash and $57 million in Carmell common and preferred shares. Additionally, there are several milestone payments, it said.

Carmell also said it has changed its name from Carmell Therapeutics Corp. to Carmell Corp. and is adopting a new brand logo to "reflect its broader focus on non-therapeutic indications in aesthetics."

Carmell Executive Chairman Rajiv Shukla said that with the closing of the Axolotl deal, Carmell is well placed to meet its "goal of profitably achieving $100 million in FY24 revenue."

US stocks look set to open Friday's trading session higher as investors eye key inflation data coming out today.

According to the Bureau of Economic Analysis' monthly personal consumption expenditures price index, personal income and personal consumption expenditures rose 0.3% and 0.5%, respectively, in June. Forecasters had expected a 0.4% rise for both.

Meanwhile, the Employment Cost Index data showed that compensation costs slowed in Q2, indicating that inflation is cooling. The index rose 1.0% in Q2 from the previous quarter, which is down from 1.2% in Q1 and just below Econoday's consensus forecast of 1.1%.

And the consumer sentiment reading from the University of Michigan, which is slated for release later this morning, is expected to close out July at a reading of 72.6, which is eight points higher than it was in June.

The Dow Jones Industrial Average futures are up 0.45%, S&P 500 futures are moving 0.67% higher, and Nasdaq futures are rising 1.06%.

Oil prices are moving marginally higher, with front-month global benchmarks Brent crude and West Texas Intermediate crude rising 0.02% and 0.04%, respectively.

In other world markets, Japan's Nikkei was off 0.40%, Hong Kong's Hang Seng ended trading 1.41% higher, and China's Shanghai Composite climbed 1.84%. Meanwhile, in Europe's early afternoon session, the UK's FTSE 100 was up 0.13%, while Germany's DAX index rose 0.20% and France's CAC nudged 0.01% higher.

On the winning side, shares of Unique Fabricating shares soared 71% in premarket activity, adding to yesterday's 12% gain. Reata Pharmaceuticals shares jumped 51% after it said it agreed to be acquired by Biogen for $172.50 per share in cash. Shares of SIGA Technologies advanced 27% after it said Thursday that the US Department of Health and Human Services exercised procurement. Greenbrook TMS shares climbed 27%, adding to Thursday's 90% gain. And shares of Coursera surged 18% after it reported a narrower loss in Q2.

On the losing side, shares of Tonix Pharmaceuticals plummeted 44% during the premarket session after it agreed to the purchase and sale of 7 million shares and warrants to purchase 7 million shares in a public offering. Sleep Number shares tumbled 26% after it reported lower fiscal Q2 earnings and sales Thursday. Shares of Bellerophon Therapeutics shed 16% after losing 2% the previous session.

Femasys shares fell 14% after soaring 131% in the previous session. And shares of Carmell Therapeutics dropped 13% after surging 46% Thursday.

US equity futures were set to open in positive territory Thursday with futures of the technology-heavy Nasdaq Composite outperforming other major benchmarks following strong quarterly earnings from Meta Platforms , while traders digested economic data including a reading on US economic growth.

Dow Jones Industrial Average futures gained 0.4%, S&P 500 futures rose 0.8%, and Nasdaq futures were 1.4% higher.

Oil prices were higher, with front-month global benchmarks North Sea Brent crude up 1.1% and US West Texas Intermediate crude up 1.4%.

US gross domestic product growth, released at 8:30 am ET, accelerated to a 2.4% annualized growth rate in Q2 versus Q1 growth of 2% and Bloomberg-compiled estimates for a smaller 1.8% gain.

Also at 8:30 am ET, data showed a 4.7% increase in new orders for durable goods in June following a 2% build in the preceding month, compared with estimates for a smaller 1.3% gain. The trade in goods deficit unexpectedly narrowed to $87.8 billion in June from $91.9 billion in May, compared with estimates for a $92 billion gap. Meanwhile, new unemployment claims fell to 221,000 in the July 22 week from 228,000 in the prior week, compared with estimates for a rise to 235,000.

At 10 am ET, the Pending Home Sales index is due for release. Analysts are expecting a 0.5% downtick for June following May's 2.7% drop.

In other world markets, Japan's Nikkei closed 0.7% higher, Hong Kong's Hang Seng closed 1.4% higher, and China's Shanghai Composite closed 0.2% lower. Meanwhile, UK's FTSE 100 gained 0.3% and Germany's DAX index rose 1.1% in Europe's early afternoon session.

In equities, shares of Meta Platforms were nearly 10% higher pre-bell after the Facebook parent reported late Wednesday Q2 earnings and revenue that topped analysts' expectations. Carmell Therapeutics shares surged 45% after the company said it has agreed to merge with regenerative medicine company Axolotl Biologics.

On the losing side, eBay shares fell 6% after the company issued Q3 adjusted profit guidance that trailed analysts' projections. Biohaven shares tumbled 26% after the company said the US Food and Drug Administration has decided not to review the company's new drug application for its genetic disorder drug troriluzole. National Vision shares fell 14%, a day after the company said its partnership with Walmart will be ending in 2024.

Carmell Therapeutics shares surged 56% Thursday premarket after the company said it has agreed to merge with regenerative medicine company Axolotl Biologics.

Mallinckrodt shares increased 29%, extending Wednesday's rally.

Osiris Acquisition shares gained 7% following a muted session.

Beard Energy Transition Acquisition Corp shares were 6% higher after closing flat in the previous session.